Rotam expands its development of dicamba in U.S.
Rotam has announced that it has acquired an EPA registration for dicamba technical and dicamba 480 SL as part of its global strategy to expand with this molecule in the U.S. Jean Michel Duhamel, Chief Commercial Officer explains: "The US market is a key focus for Rotam as it seeks to continue its rapid growth globally. Dicamba is the first of several molecules Rotam will bring to the US market within the next few years. It will be commercialized under the name of Topeka."
Rotam has the ambition to become one of the leading alternative sources of dicamba in the next decade which implies being present in key markets like USA as well as in the EU where the molecule is already registered and sold (France, UK and Italy).
Besides, the company is implementing its Innovation Proprietary Post Patent strategy by evaluating new dicamba based mixtures in order to provide unique herbicide solution with stronger agronomic value to the maize growers.